- Article
The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib
- Pawel Robak,
- Dariusz Jarych,
- Damian Mikulski,
- Izabela Dróżdż,
- Edyta Węgłowska,
- Aleksandra Kotkowska,
- Małgorzata Misiewicz,
- Piotr Smolewski,
- Konrad Stawiski and
- Wojciech Fendler
- + 2 authors
Proteasome inhibitors, like bortezomib, play a key role in the treatment of multiple myeloma (MM); however, most patients eventually relapse and eventually show multiple drug resistance, and the molecular mechanisms of this resistance remain unclear....